Tenth of Ramadan for Pharmaceutical Industries and Diagnostic Reagents (Rameda) (S.A.E) (EGX:RMDA)

Egypt · Delayed Price · Currency is EGP

4.380

+0.380 (9.50%)

At close: Feb 23, 2026

Revenue by Segment

Financials in millions EGP. Fiscal year is January - December.

Millions EGP. Fiscal year is Jan - Dec.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016	FY 2015
Period Ending	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019	Dec '18 Dec 31, 2018	Dec '17 Dec 31, 2017	Dec '16 Dec 31, 2016	Dec '15 Dec 31, 2015
Sales of Pharmaceutical Products	2.59B	1.79B	1.35B	1.17B	909.33M
Sales of Pharmaceutical Products Growth	44.65%	32.32%	15.62%	28.55%	6.81%
Services Toll Manufacturing	181.87M	134.01M	132.44M	77.49M	50.84M
Services Toll Manufacturing Growth	35.71%	1.18%	70.91%	52.42%	19.39%
Total	2.77B	1.92B	1.48B	1.25B	960.17M
Total Growth	44.03%	29.54%	19.06%	29.81%	7.41%

Revenue by Geography

Financials in millions EGP. Fiscal year is January - December.

Millions EGP. Fiscal year is Jan - Dec.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016	FY 2015
Period Ending	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019	Dec '18 Dec 31, 2018	Dec '17 Dec 31, 2017	Dec '16 Dec 31, 2016	Dec '15 Dec 31, 2015
Egypt	2.63B	1.74B	1.38B	1.16B	910.23M
Egypt Growth	50.76%	26.47%	18.89%	27.28%	9.82%
Export	142.20M	180.24M	106.51M	87.87M	49.94M
Export Growth	-21.11%	69.23%	21.21%	75.96%	-23.29%
Total	2.77B	1.92B	1.48B	1.25B	960.17M
Total Growth	44.03%	29.54%	19.06%	29.81%	7.41%

Source: S&P Global Market Intelligence.